Sham-litigation probe of Sanofi-owned Genzyme closed in Brazil
A probe of Sanofi-owned Genzyme Corp. and subsidiary Genzyme do Brasil, under which they were accused of launching sham litigation to block competitors in the market for drugs that treat high...To view the full article, register now.
Already a subscriber? Click here to view full article